4//SEC Filing
Bausch Christoph Lawrence 4
Accession 0000950170-24-019434
CIK 0001833214other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:50 PM ET
Size
5.6 KB
Accession
0000950170-24-019434
Insider Transaction Report
Form 4
Bausch Christoph Lawrence
CHIEF OPERATING OFFICER
Transactions
- Award
Employee Stock Option (right to buy)
2024-02-21+140,000→ 140,000 totalExercise: $5.17Exp: 2034-02-21→ Common Stock (140,000 underlying)
Footnotes (2)
- [F1]Represents options to purchase shares of common stock pursuant to the Company's 2021 Omnibus Equity Incentive Plan.
- [F2]The shares underlying the option vest over a four-year period, vesting 1/4 on the one-year anniversary of the date of grant, and the remaining 3/4 vesting pro rata on a monthly basis in 36 equal installments thereafter.
Documents
Issuer
SAB Biotherapeutics, Inc.
CIK 0001833214
Entity typeother
Related Parties
1- filerCIK 0001889981
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:50 PM ET
- Size
- 5.6 KB